Therapeutic drug monitoring: Difference between revisions
Created page with "{{:Stub}} = measurement of drug concentration or activity in plasma * Methods ** High performance liquid chromatography ** Immunoassay * Indications ** Non-linear kinetics of drug ** When there is poor compliance ** If the therapeutic effect can’t be assessed clinically ** If the therapeutic index is low *** Warfarin *** Aminoglycosides *** Antipsychotics *** Digoxin *** Lithium ** When there are signs of overdose ** To determine pharmacokinetic interactions Categ..." |
No edit summary |
||
| Line 1: | Line 1: | ||
{{:Stub}} | {{:Stub}} | ||
<section begin="clinical biochemistry" /> | |||
= measurement of drug concentration or activity in plasma | = measurement of drug concentration or activity in plasma | ||
| Line 18: | Line 18: | ||
** When there are signs of overdose | ** When there are signs of overdose | ||
** To determine pharmacokinetic interactions | ** To determine pharmacokinetic interactions | ||
<section end="clinical biochemistry" /> | |||
[[Category:Laboratory Medicine]] | [[Category:Laboratory Medicine]] | ||
Latest revision as of 11:07, 18 June 2024
This article is a stub, meaning that it is unfinished. It will eventually be expanded.
= measurement of drug concentration or activity in plasma
- Methods
- High performance liquid chromatography
- Immunoassay
- Indications
- Non-linear kinetics of drug
- When there is poor compliance
- If the therapeutic effect can’t be assessed clinically
- If the therapeutic index is low
- Warfarin
- Aminoglycosides
- Antipsychotics
- Digoxin
- Lithium
- When there are signs of overdose
- To determine pharmacokinetic interactions